An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness
Mohammad Asif(Jodhpur National University), Timothy J. Regan, Anthony Cerami(Araim Pharmaceuticals (United States)), John J. Egan, Michael Brines(Northwell Health), Chandra Williams, Dilip Wagle, G.N. Jyothirmayi, Sara Vasan, Santos Lopez, Malthi Masurekar, Peter Ulrich(University of Potsdam), Ramón L. Torres
Cited by 334
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654